Back
Las Vegas Sands 10K Form
Buy
57
LVS
Las Vegas Sands
Last Price:
41.98
Seasonality Move:
-0.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-19 | 10Q | LVS/Las Vegas Sands Quarterly |
2023-10-20 | 10Q | LVS/Las Vegas Sands Quarterly |
2023-07-21 | 10Q | LVS/Las Vegas Sands Quarterly |
2023-04-21 | 10Q | LVS/Las Vegas Sands Quarterly |
2022-10-21 | 10Q | LVS/Las Vegas Sands Quarterly |
2022-07-22 | 10Q | LVS/Las Vegas Sands Quarterly |
Receive LVS News And Ratings
See the #1 stock for the next 7 days that we like better than LVS
LVS Financial Statistics
Sales & Book Value
Annual Sales: | $10.37B |
---|---|
Cash Flow: | $525M |
Price / Cash Flow: | 14.22 |
Annual Sales: | $5.10 |
Price / Book: | 8.24 |
Profitability
EPS (TTM): | 2.14000 |
---|---|
Net Income (TTM): | $1.61B |
Gross Margin: | $5.17B |
Return on Equity: | 38.99% |
Return on Assets: | 7.41% |
Las Vegas Sands Earnings Forecast
Key Las Vegas Sands Financial Ratios
- The Gross Profit Margin over the past 20 years for LVS is 49.82%.
- The Selling, General & Administrative Expenses for LVS have been equal to 10.67% of Gross Profit Margin.
- The Research & Development expenses have been 1.98% of Revenue.
- The Interest Expense is 66.99% of Operating Income.
- The Net Earning history of LVS is 11.77% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 12 years.
Las Vegas Sands Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Hotels, Restaurants & Leisure |
Sector: | Consumer Discretionary |
Current Symbol: | LVS |
CUSIP: | 517834 |
Website: | sands.com |
Debt
Debt-to-Equity Ratio: | 3.66 |
---|---|
Current Ratio: | 1.58 |
Quick Ratio: | 1.53 |
Price-to-Earnings
Trailing P/E Ratio: | 26.24 |
---|---|
Forward P/E Ratio: | 14.97 |
LVS Technical Analysis vs Fundamental Analysis
Buy
57
Las Vegas Sands (LVS)
is a Buy
Is Las Vegas Sands a Buy or a Sell?
-
Las Vegas Sands stock is rated a Buy
The current Las Vegas Sands [LVS] share price is $41.98. The Score for LVS is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.